Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Appointed director
|
HealthWarehouse.com, Inc. (HEWA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/13/2017 |
8-K
| Form 8-K - Current report |
08/11/2016 |
8-K
| Quarterly results |
05/17/2016 |
8-K
| Quarterly results |
04/06/2016 |
8-K
| Quarterly results |
11/17/2011 |
8-K
| Form 8-K - Current report |
08/16/2011 |
8-K
| Form 8-K - Current report |
05/24/2011 |
8-K
| Form 8-K - Current report |
04/18/2011 |
8-K
| Quarterly results
Docs:
|
"HealthWarehouse.com Reports 278% Year-Over-Year Prescription Growth Gross Margins Increase From 30.4% to 39.4% Year-Over-Year CINCINNATI, April 18, 2011 -- HealthWarehouse.com, Inc. a leading VIPPS accredited retail mail-order pharmacy, today announced its financial results for the year ended December 31, 2010. For the year ended December 31, 2010, the Company’s net sales increased $1,908,223 to $5,691,765, up 50% compared to the same period in 2009. This was driven by growth in the Company’s prescription business. Prescriptions filled increased from 17,855 to 67,577, up 278% year-over-year. Gross margins increased from 30.4% to 39.4% year-over-year due to prescription orders becoming a larger part of the product mix. Selling, general and administrative expenses increased by $1,656,702 for..." |
|
11/16/2010 |
8-K
| Quarterly results
Docs:
|
"HealthWarehouse.com Reports 203% Prescription Growth in the Third Quarter 2010 Compared to 2009 Gross Margins Increase From 34.6% to 41.6% Year Over Year CINCINNATI, November 16th, 2010 -- HealthWarehouse.com, Inc. a leading VIPPS accredited retail mail-order pharmacy, today announced its financial results for the third quarter ended September 30th, 2010. In the third quarter of 2010, the Company’s quarterly net sales increased $208,866 to $1,215,476, up from $1,006,610, compared to the same period in 2009, driven by growth in its prescription business. Prescriptions filled increased 12,215 to 18,218, up from 6,003, compared to the same period in 2009. Gross margins increased from 34.6% to 41.6% year-over-year. Selling, general and administrative expenses increased by $339,999 for the thre..." |
|
08/17/2010 |
8-K
| Form 8-K - Current report |
05/18/2010 |
8-K
| Quarterly results |
11/25/2009 |
8-K
| Form 8-K - Current report |
03/16/2006 |
8-K
| Quarterly results |
|
|